Compare SONO & AXGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SONO | AXGN |
|---|---|---|
| Founded | 2002 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Consumer Electronics/Video Chains | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.8B | 1.5B |
| IPO Year | 2018 | N/A |
| Metric | SONO | AXGN |
|---|---|---|
| Price | $15.34 | $34.28 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 9 |
| Target Price | $19.67 | ★ $33.67 |
| AVG Volume (30 Days) | ★ 1.5M | 1.1M |
| Earning Date | 02-03-2026 | 02-24-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $1,438,081,000.00 | $214,709,000.00 |
| Revenue This Year | $3.93 | $21.87 |
| Revenue Next Year | $8.33 | $15.69 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 18.72 |
| 52 Week Low | $7.63 | $9.22 |
| 52 Week High | $19.82 | $36.00 |
| Indicator | SONO | AXGN |
|---|---|---|
| Relative Strength Index (RSI) | 43.58 | 58.56 |
| Support Level | $14.12 | $33.02 |
| Resistance Level | $15.14 | $36.00 |
| Average True Range (ATR) | 0.72 | 1.48 |
| MACD | 0.02 | 0.09 |
| Stochastic Oscillator | 36.57 | 70.25 |
Sonos Inc is an audio company dedicated to elevating life through sound, offering a connected platform that brings together music, movies, stories, and conversations. Its portfolio includes home theater speakers, components, plug-in and portable speakers and headphones, known for exceptional sound, thoughtful design, ease of use and seamless access to audio content. Its partner products and other revenue categories include accessories for home integration, such as custom-designed stands, mounts, and shelving units, along with partnerships for architectural speakers and automotive sound systems, as well as licensing, advertising revenue, and subscription-based services. The company operates in the United States and other countries, with the majority of revenue coming from the United States.
Axogen Inc is engaged in the science, development, and commercialization of technologies for peripheral nerve regeneration and repair. The company provides clinically, economically effective repair solutions for surgeons and health care providers. Its products include Avance Nerve Graft, Axoguard Nerve Connector, Axoguard Nerve Protector, Axoguard Nerve Cap and Avive Soft Tissue Membrane. It also offers an Axotouch Two-Point Discriminator used to measure the innervation density of any surface area of the skin. Its products are available in the United States, Canada, Germany, the United Kingdom, Spain, South Korea, and several other countries.